Event

Peter M. Calverley

DSc, F MedSci
Clinical Science Centre, Institute of Ageing and Chronic Disease, University of Liverpool;Institute of Ageing and Chronic Disease, University of Liverpool;University of Liverpool;University of Liverpo

Gary T. Ferguson

MD
Pulmonary Research Institute of Southeast Michigan

Florian Voss

-
Boehringer Ingelheim Pharma GmbH & Co. KG

Alberto de la Hoz

MD
Boehringer Ingelheim Pharma GmbH & Co. KG

Antonio Anzueto

MD
South Texas Veterans Health Care System and University of Texas;Univ of Texas Hlth Sci Ctr at San Antonio;University of Texas Health – Medicine San Antonio;University of Texas Health Sciences Center a

Roland Buhl

Prof.Dr.med
Johannes Gutenberg University Hospital Mainz;Johannes Gutenberg University Mainz;Mainz University Hospital

Ulrich Bothner

MD, MSc
Boehringer Ingelheim Pharma GmbH & Co. KG

Safety of Tiotropium/Olodaterol in Chronic Obstructive Pulmonary Disease: Pooled Analysis of Three Large, 52-Week, Randomized Clinical Trials